Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of EVT 101 in Treatment-Resistant Depression

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Major Depressive Disorder~* Current episode of major depression that has not benefited from at least 1 but no more than 3 adequate treatment regimens~* Has as score of \>/= 18 on the Ham-D-17~Exclusion Criteria:~* Pregnant or breast-feeding women~* Evidence of age-related cognitive decline or mild dementia~* At imminent risk of committing suicide~* Has with the exception of major depression, a serious medical or neurological illness, including seizure disorder, stroke, dementia, or Parkinson disease~* Has an established diagnosis of bipolar disorder, hypomania, schizoaffective disorder, major depression with psychotic features or schizophrenia~* Has had a substance or alcohol abuse or dependence disorder (except nicotine and caffeine) in the 1 year before screening

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Placebo
- EVT 101 (Type: EXPERIMENTAL): EVT 101

Based on this trial design, predict the completion outcome and termination type (if applicable).